NovaBay Pharmaceuticals, Inc. (NBY) A nticipated to Post Revenue of -$0.04 Per Share

... Auriclosene Irrigation Solution for urology; CelleRx for the dermatology market; intelli-Case, a device for soft and rigid gas permeable contact lenses ...

source http://bharatapress.com/2018/11/24/novabay-pharmaceuticals-inc-nby-expected-to-post-earnings-of-0-04-per-share/